The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor

FASEB Journal

Volumn 19, Issue 7, 2005, Pages 780-782

  Johns, Terrance G ^a   Mellman, Ira ^c   Cartwright, Glenn A ^a   Ritter, Gerd ^d   Old, Lloyd J ^d   Burgess, Antony W ^b   Scott, Andrew M ^a  

^a AUSTIN HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MANNOSE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 806; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURFACE; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; RECEPTOR BINDING;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ASTROCYTOMA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MEMBRANE; DIMERIZATION; ENDOPLASMIC RETICULUM; EPITOPES; GENE AMPLIFICATION; GENE EXPRESSION; GLYCOSYLATION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOSORBENT TECHNIQUES; MANNOSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18144426053     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-1766fje     Document Type: Article

References (0)